Edition:
United Kingdom

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

26.83USD
23 Oct 2018
Change (% chg)

$0.02 (+0.07%)
Prev Close
$26.81
Open
$26.05
Day's High
$27.32
Day's Low
$25.80
Volume
329,211
Avg. Vol
255,235
52-wk High
$45.02
52-wk Low
$20.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 7.37 -0.825
Mar '18 3.93 -0.673
FY 2017 Dec '17 3.67 -0.849
Sep '17 6.28 -0.644
Jun '17 3.10 -0.648
Mar '17 0.68 -0.852
FY 2016 Dec '16 0.90 -1.101
Sep '16 0.96 -0.592
Jun '16 3.39 -0.540
Mar '16 0.81 -0.799
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 10.08 32.20 1.80 6.00
Quarter Ending Mar-19 4 5.60 7.00 3.81 --
Year Ending Dec-18 10 35.21 66.00 15.00 19.63
Year Ending Dec-19 10 30.37 58.10 16.30 21.01
Earnings (per share)
Quarter Ending Dec-18 9 -0.68 -0.12 -1.03 -1.13
Quarter Ending Mar-19 5 -0.83 -0.67 -1.04 --
Year Ending Dec-18 9 -2.78 -1.98 -3.32 -2.85
Year Ending Dec-19 9 -3.24 -2.68 -4.26 -3.13
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.35 33.64
P/E High - Last 5 Yrs. -- 287.14 45.18
P/E Low - Last 5 Yrs. -- 89.68 23.74
Beta -- 0.93 0.88
Price to Sales (TTM) 185.11 124.53 5.83
Price to Book (MRQ) 5.53 15.28 4.89
Price to Tangible Book (MRQ) 5.64 14.51 6.51
Price to Cash Flow (TTM) -- 70.04 22.92
% Owned Institutions 85.00 14.28 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.41
Payout Ratio(TTM) -- 16.74 43.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.59 411.24 8.09
Sales (TTM) vs TTM 1 Yr. Ago -0.28 103.59 5.81
Sales - 5 Yr. Growth Rate -- 30.71 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.99 23.99 23.40
EPS (TTM) vs TTM 1 Yr. Ago -67.60 -- --
EPS - 5 Yr. Growth Rate -- 37.59 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.51 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 6.73 5.36 3.05
LT Debt to Equity (MRQ) 18.31 34.91 12.79
Total Debt to Equity (MRQ) 26.42 36.72 17.21
Interest Coverage (TTM) -- -97.07 37.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.06 54.86
Gross Margin - 5 Yr. Avg. -- 48.98 52.38
EBITD Margin (TTM) -2,036.53 -- --
EBITD - 5 Yr. Avg -- -578.76 11.01
Operating Margin (TTM) -2,072.90 -789.30 4.03
Operating Margin - 5 Yr. Avg. -- -599.86 6.34
Pre-Tax Margin (TTM) -2,091.36 -751.43 5.08
Pre-Tax Margin - 5 Yr. Avg. -- -605.48 6.78
Net Profit Margin (TTM) -2,091.36 -752.40 1.35
Net Profit Margin - 5 Yr. Avg. -- -608.15 3.03
Effective Tax Rate (TTM) -- 23.50 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.68 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 63,360 22,659,931 807,592,034
Net Income/Employee (TTM) -1,325,079 1,701,937 94,981,854
Receivable Turnover (TTM) 5.60 20.75 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.02 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -38.14 -1.42 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -42.42 0.18 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -63.35 1.14 15.99
Return on Equity - 5 Yr. Avg. -- 2.73 16.87
  1 Year 3 Year 5 Year
Sales % 271.58 -- --
EPS (TTM) % -46.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Editas Medicine Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.49 20.20 99 58
13 Week 45.58 38.49 99 61
26 Week 19.67 10.57 99 78
52 Week 66.62 41.23 99 47
YTD 54.10 35.33 99 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.00%
# of Holders: 285
Total Shares Held: 35,278,560
3 Mo. Net Change: 692,890
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 16
# Reduced Positions: 12
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.